Aug 21
Congratulations to REUs Argerie Guevara (NURF’21), and Kevin Armknecht (NURF’23) and Carlie Kudary (#BIPH) on the prolonged antibacterial action formulation of standard antibiotics to tackle MRSA and P.aeruginosa. More to come this year. #AMR #GOIRISH https://doi.org/10.1093/milmed/usae079
Jun 19
I am super thrilled to have organized and chaired the session on “Precision Health and Diagnostics” at Techconnect 2024, which was held from June 17 to 19 at National Harbor in Maryland. Precision health and diagnostics have revolutionized treatment regimens by replacing them with ones that are more effective, less toxic, and positively impact survival. …
May 24
Really useful information on working with the DoD’s medical enterprise. MTEC annual meeting in Baltimore, MD. Phage Mimicking antibacterial nanoparticles was a hit. New Partnering opportunity on the horizon. Exciting times ahead! #GOIRISH #MTEC #AMR #NEXTGEN #ANTIBIOTICS
May 03
Celebrating two publications and a productive end to the academic year with a group dinner at Howard Park Public House. Also, we are celebrating Kevin, who was the first undergraduate in ND’s history to win an outstanding publication image award from the NDIIF Core Facility and was invited to present at the 9th Annual Midwest …
Apr 15
The Nallthamby lab participated in the 12th annual Cancer Research Day. This event showcased HCRI’s multidisciplinary cancer research and featured poster sessions, oral presentations, a keynote presentation, and awards. This year’s keynote, Cancer Care Statewide: The Impact of Clinical &Translational Cancer Research was given by Nicholas J. Petrelli, MD, FACS, Bank of America Endowed Medical Director at the Helen F. Graham Cancer Center and Research Institute, ChristianaCare. …
Mar 01
Our manuscript titled, “PLGA nanoparticles formulations loaded with antibiotics induce sustained and controlled antibiotics release for prolonged antibacterial action against MRSA, and Pseudomonas aeruginosa FRD1” (MILMED-D-23-00750R1), has been accepted for publication. This is the first time we are publishing in the supplement to the Military Health Sciences Research Symposium. The manuscript was based on our …
Jul 07
Congratulations to Nallathamby lab’s @JohannaOlesk on successfully defending her Masters thesis for Bioengineering in Summer 2023. Her thesis was titled ” Phage-Mimicking Nanoparticles Conjugated with Antimicrobial Peptides and Polymers as an Alternative to Antibiotic Treatment.” She passed with unanimous consent. We wish her all the best in her future undertakings. #WomenInSTEM#notredame#GoIrish Special mention to all …
Jun 17
We were excited to present our work titled, “Biomimetic, Antibiotic Free, Nanoparticles for Agent Agnostic Broad Spectrum Antimicrobial Action including ESKAPE Pathogens” [Abstract 557] at the 2023 TechConnect World Innovation Conference in National Harbor, MD (June 19-21, 2023), as part of the Precision Health and Diagnostics symposium. Our talk was well received. We got lots of useful …
May 23
Nallathamby group’s work on “Phage-mimicking, Broad-spectrum, antibacterial nanoparticles” was showcased at MTEC’s annual meeting in Richmond, Virginia. I am proud to represent Notre Dame and the Berthiaume Institute for Precision Health at the 8th annual meeting of MTEC to learn firsthand the medical needs of the DoD. Our focus on combating antimicrobial resistance using phage …
May 01
Congratulations to @Argerie Guevara (CBE’23) for taking the thesis option in her undergraduate research and passing it with unanimous consensus today. Her thesis was titled, “PLGA nanoparticles formulations loaded with antibiotics induce sustained and controlled antibiotics release for prolonged antibacterial action against MRSA, and Pseudomonas aeruginosa FRD1,” and is currently being peer-reviewed for publication. Argerie is currently …
NIH Funding Opportunities
Recent Comments